From Frozen to Dynamic: A Paradigm Shift in Real-World Data Utilization

Frozen Dataset Image

Real-World Data (RWD) has been a cornerstone of the Life Sciences industry for decades, driving research, guiding clinical decisions, and informing policy. With recent FDA updates, the role of RWD continues to expand. However, traditional data extraction methods often result in “frozen” datasets, which pose significant challenges in a world that increasingly demands agility, updatability, […]

Turning Hospitals Into Active Participants in Pharmaceutical Research

Hospitals as data-providers for pharmaceutical research

Today, data is one of the most valuable assets hospitals possess, with the global healthcare real-world data market estimated to be valued at $4 billion by 2030. Beyond improving patient care, this data can contribute to groundbreaking research, fuel advancements in medical science, and improve clinical outcomes. Healthcare data accounts for an estimated 30% of […]

Driving Clinical Innovation Through Real-World Data: Briya’s Strategic Collaboration with MSD

Briya MSD collaboration preview image

The future of healthcare is being reshaped by a wave of data-driven discovery, unleashing limitless potential for medical breakthroughs. With technology that enables unbounded access to vast, interconnected patient-level datasets, the healthcare industry is empowered to explore the complex fabric of human health in ways previously unimaginable. We’re now able to pull a needle from […]

5 Ways Real-Time Data is Revolutionizing Clinical Trials: Accelerating Research and Boosting ROI

Real-time data for clinical trials blog image

Even though clinical trials are essential for gaining indispensable insights into treatments and obtaining regulatory approval for drug development, the administrative landscape of these trials proves to be challenging and difficult to navigate. With prevalent challenges such as patient recruitment and retention, increased complexity, and harsh regulatory hurdles, clinical trials often become extremely expensive and […]

New FDA Guidelines on Real-World Data: Implications for Healthcare Research and Innovation

The U.S. Food and Drug Administration (FDA) has recently released final guidance on the use of Real-World Data (RWD) in regulatory decision-making for drug and biological products. This landmark document, focusing on electronic health records (EHRs) and medical claims data, marks a significant step forward in the healthcare industry’s approach to drug development and approval […]

The Value of Briya’s Maternal Health Data

One way to address the shortcomings of maternal health care is by facilitating the proper utilization of patient data. As in most industries, the actual availability of data isn’t the problem: with the digitization of health records, prescriptions, and test results, HMOs and hospitals, in theory, sit on a wealth of data that encompasses nearly […]

The Importance of Shortening Time to Medical Data

It takes 8 to 12 months to gain access to the right medical data. In today’s fast-paced world, the timely availability of medical data is crucial for improving patient outcomes and advancing healthcare research. Delays in accessing real-world data can hinder the effectiveness of treatment plans, slow down the development of new therapies, and impede […]

The Rise of Real-World Evidence: Transforming Healthcare Through Patient Data

The healthcare landscape is being reshaped by the increasing adoption of real-world data (RWD) and real-world evidence (RWE). These emerging disciplines have the potential to revolutionize medical research, drug development, and clinical decision-making by harnessing insights from diverse patient data sources beyond traditional clinical trials. Understanding RWD Sources RWD encompasses a wide array of health-related […]